Form D — Nacuity Pharmaceuticals, Inc.
0001690279-25-000002 · filed 2025-12-30
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $30,000,000
- Total sold
- $8,393,350
- Minimum investment
- $9,375
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nacuity Pharmaceuticals, Inc.
- CIK
- 1690279
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- FORT WORTH CLUB BLDG.
FORT WORTH, TX 76102 - Phone
- 817-336-3000
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Halden Conner · Executive OfficerFort Worth, TX Find on LinkedIn ↗
-
David Wohlberg · Executive OfficerFort Worth, TX Find on LinkedIn ↗
-
Gerald Cagle · DirectorFort Worth, TX Find on LinkedIn ↗
-
Emmett Cunningham, Jr. · DirectorFort Worth, TX Find on LinkedIn ↗
-
Rusty Kelley · DirectorFort Worth, TX Find on LinkedIn ↗
-
Robin Steele · DirectorFort Worth, TX Find on LinkedIn ↗
-
Benjamin Yerxa · DirectorFort Worth, TX Find on LinkedIn ↗
-
Jami Kern · Executive OfficerFort Worth, TX Find on LinkedIn ↗
-
Charles Lieser · Executive OfficerFort Worth, TX Find on LinkedIn ↗
-
Michael Wall · Executive OfficerFort Worth, TX Find on LinkedIn ↗
View original on SEC EDGAR.